AASLD – The Liver Meeting
Nov 15, 2024 at 1:00 PM PST
Presentation Title: Effect of Pemvidutide, a GLP-1/Glucagon Dual Receptor Agonist, on Plasma Lipidomic Profiles in Subjects with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Speaker: Sarah Browne, M.D., Vice President, Clinical Development, Altimmune
